Cell Based Services
Cell Based Assays
Cell-based assays are a vital early step in the testing of your compounds and drug candidates for activity. Outsourcing cell assays is an affordable and proven method for success.
Apoptosis assay
Caspase, DNA fragmentation
Immune Modulation and Stimulation
Lymphocyte isolation proliferation
a. Naïve and LPS treated lymphocytes
b. Naïve and PHA induced
Wrinkle, Ageing Studies
Collagen release
Cell Culture Studies
Cryopreservation, Revival of cells, Sub-culturing of cells, Cell counting, Cell seeding, Primary cell culture,
Cell growth study,Mycoplasma testing,Cell transfection (Stable and Transient),Co-culture (Contact, transwell system).
Diabetes/Obesity studies
Adipogenesis, Stimulation and inhibition of lipolysis (FFA), Oil red O staining, Triglyceride accumulation, Gluconeogenesis
Anti-oxidant, Inflammation, Pain studies
Nitric Oxide release, Nitric Oxide scavenging
Cytotoxicity Proliferation Viability assays
MTT, SRB, CCK-8
Oncology
Tumor cell lines (Breast, lung, skin, pancreatic, liver, bone) ,High throughput screening of pre-clinal drugs ,
GI-50 evaluation in tumor cell lines, IC-50 evaluation in tumor cell lines
COPD/Asthma models
Oxidative stress (H2O2)
Inflammation, Allergy Studies
IL-1 beta inhibition, TNF alpha inhibition, IL-6 inhibition, Whole blood assays, Human PBMC assays
PLEASE GET IN TOUCH FOR FURTHER DETAILS, OR IF YOU HAVE ANY QUESTIONS ABOUT OUR CELL BASED SERVICES.
Disclaimer
The in-vitro bioassays given in this list / catalogue are being offered under company’s contract research program. In-house standardized assay protocols will be used to perform these assays. The company is committed to ensure that utmost care is taken to adhere to specified protocols towards providing accurate and factual results to the users of this service. However, further use of the results and analytical reports provided by us for any commercial purposes is the sole responsibility of the user and we do not make any representation that the use of the bioassay reports will not infringe any intellectual property rights of third parties. In no event shall Hanugen Therapeutics Private Limited be liable to any party for any direct, indirect, special or other consequential damages for any commercial use of the bioassay reports provided by Hanugen Therapeutics Private Limited.